PHARMACOKINETICS AND THE EFFECT OF PROBENECID ON THE RENAL EXCRETION MECHANISM OF DIPROPHYLLINE

被引:10
作者
NADAI, M [1 ]
APICHARTPICHEAN, R [1 ]
HASEGAWA, T [1 ]
NABESHIMA, T [1 ]
机构
[1] NAGOYA UNIV,SCH MED,DEPT HOSP PHARM,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
关键词
D O I
10.1002/jps.2600811014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The mechanism of renal excretion of diprophylline (DPP) and the effect of probenecid on the active transport of DPP in renal tubules were investigated in rats. The concentration of DPP in plasma increased in proportion to the doses of 10, 30, and 60 mg/kg. The pharmacokinetic parameters and the urinary excretion of DPP did not change significantly with the dose. These findings indicate that DPP possesses dose-independent pharmacokinetics. Pharmacokinetic parameters for tubular secretion of DPP, as determined by a single-injection renal clearance method, were 21.25 mug/mL for the Michaelis-Menten constant and 102.38 mug/min for maximum velocity. Coadministration of probenecid decreased the total body clearance of DPP but did not change in the steady-state volume of distribution of DPP. The effect of probenecid concentration on the steady-state renal clearance of DPP was evaluated by continuously infusing probenecid at various rates. The renal clearance of DPP decreased as the probenecid concentration increased, a result indicating that probenecid inhibits the tubular secretion of DPP. However, probenecid did not inhibit the renal secretion of DPP completely, probably because of the existence of probenecid-insensitive transport systems for DPP in the renal proximal tubule. The Michaelis-Menten constant, maximum velocity, and glomerular filtration rate, as calculated with the competitive inhibition model for renal clearance ot DPP, correlated well with estimated values after a single intravenous administration, as described earlier The competitive inhibition constant of probenecid was 15.86 mug/mL.
引用
收藏
页码:1024 / 1027
页数:4
相关论文
共 19 条
  • [1] ACARA M, 1986, J PHARM PHARMACOL, V39, P526
  • [2] ANDERSSON KE, 1985, ANTI ASTHMA XANTHINE, P223
  • [3] EFFECTS OF PROBENECID ON ENPROFYLLINE KINETICS IN MAN
    BORGA, O
    LARSSON, R
    LUNELL, E
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (02) : 221 - 223
  • [4] DISCHE Z, 1951, J BIOL CHEM, V192, P583
  • [5] PHARMACOKINETICS OF ORALLY-ADMINISTERED DYPHYLLINE
    GISCLON, LG
    AYRES, JW
    EWING, GH
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (09): : 1179 - 1184
  • [6] EFFECT OF MEQUITAZINE ON THE PHARMACOKINETICS OF THEOPHYLLINE IN ASTHMATIC-PATIENTS
    HASEGAWA, T
    TAKAGI, K
    KUZUYA, T
    NADAI, M
    APICHARTPICHEAN, R
    MURAOKA, I
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (03) : 255 - 258
  • [7] PHARMACOKINETIC CHARACTERISTICS OF N7-SUBSTITUTED THEOPHYLLINE DERIVATIVES AND THEIR INTERACTION WITH QUINOLONE IN RATS
    HASEGAWA, T
    NADAI, M
    APICHARTPICHEAN, R
    MURAOKA, I
    NABESHIMA, T
    TAKAGI, K
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) : 962 - 965
  • [8] EFFECT OF PROBENECID ON THE RENAL AND NONRENAL CLEARANCES OF ZIDOVUDINE AND ITS DISTRIBUTION INTO CEREBROSPINAL-FLUID IN THE RABBIT
    HEDAYA, MA
    SAWCHUK, RJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (09) : 716 - 722
  • [9] PHARMACOKINETIC ANALYSIS OF RENAL HANDLING OF SULFAMETHIZOLE
    HORI, R
    SUNAYASHIKI, K
    KAMIYA, A
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (03) : 463 - 465
  • [10] MAY DC, 1981, NEW ENGL J MED, V304, P791